Issue Date: September 1, 2008
Codexis Expands Its Partnership With Arch
Codexis and Mumbai-based Arch Pharmalabs have expanded an existing three-year supply deal. Under the new agreement, Arch will exclusively manufacture Codexis' active pharmaceutical ingredients (APIs) and intermediates at its 10 facilities in India. Codexis develops routes for making brand-name and generic APIs using biocatalytic processes. Among the products to be manufactured are intermediates used to make generic atorvastatin, the active ingredient in Pfizer's cholesterol-lowering drug Lipitor, as well as the API itself.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society